Zhenyuan Yang - Publications

ASO Author Reflections: Beyond Tumor Biology: Integrating Host Physiological Reserve into Perioperative Esophageal Cancer Care.

Journal: Annals of surgical oncology

Published: July 10, 2026

Author Correction: Multi-omics profiling reveals tumor microenvironment characteristics linked to immunotherapy response and prognosis in non-small cell lung cancer.

Journal: NPJ precision oncology

Published: June 04, 2026

Pretreatment thymic computed tomography density predicts pathological response and survival after neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: June 01, 2026

Predicting Anastomotic Leak After Neoadjuvant Chemoimmunotherapy and Esophagectomy: A Dynamic Inflammatory and Nutritional Biomarker Model.

Journal: Journal of inflammation research

Published: April 21, 2026

Preoperative Nutritional Risk Defines Treatment Tolerance and Guides Adjuvant Immunotherapy in Resectable Esophageal Squamous Cell Carcinoma.

Journal: Annals of surgical oncology

Published: March 24, 2026

Efficacy and safety of neoadjuvant chemotherapy with immunotherapy versus chemotherapy alone in esophageal squamous cell carcinoma: a meta-analysis based on randomized controlled trials.

Journal: Frontiers in immunology

Published: March 08, 2026

Neoadjuvant camrelizumab combined with radiotherapy as a chemotherapy-sparing approach for resectable locally advanced esophageal squamous cell carcinoma: a phase II clinical trial (ESOCORT-NIRT).

Journal: BMC medicine

Published: December 30, 2025

Lymphovascular and perineural invasion guides adjuvant therapy after neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma.

Journal: The oncologist

Published: December 23, 2025

Prognostic impact of advanced lung cancer inflammation index and tumor load index in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy.

Journal: Frontiers in immunology

Published: October 13, 2025

Prediction of clinically significant complication following neoadjuvant chemoimmunotherapy in resectable esophageal cancer: a dynamic systemic inflammatory biomarker-based model.

Journal: Frontiers in immunology

Published: October 06, 2025

Multi-omics profiling reveals tumor microenvironment characteristics linked to immunotherapy response and prognosis in non-small cell lung cancer.

Journal: NPJ precision oncology

Published: August 28, 2025

Comparison of subcutaneous tunnel-assisted periareolar incision versus conventional uniportal video-assisted thoracoscopic surgery (VATS) for pulmonary nodules: A prospective, randomized, controlled trial.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: June 18, 2025